Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2020-05-14 2020-05-14
Drug Identification Number 02370492 02370492
Brand name ACT DILTIAZEM T ACT DILTIAZEM T
Common or Proper name ACT- DILTIAZEM T 180MG TAB ACT- DILTIAZEM T 180MG TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients DILTIAZEM HYDROCHLORIDE DILTIAZEM HYDROCHLORIDE
Strength(s) 180MG 180MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code C08DB C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2020-05-08 2020-05-08
Actual discontinuation date 2020-05-08 2020-05-08
Remaining supply date 2020-05-08 2020-05-08
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments